Just Other Articles - Internet and Businesses Online

By now you've probably noticed the onslaught of unfamiliar domain name extensions popping up her

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e and there. Like most domain name professionals, you've probably sat at your computer ponderin

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

whether or not you should kick out the extra cash to register some of these domain names... why

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Keywords! While droves of individuals place an extreme value on the domain names extension, I

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

firmly believe that the extension has nothing to do with the success or failure of the domain na

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

me. While certain ccTLD's (Country Code Top Level Domains) gain popularity, others leave little

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

to be desired. Mostly because of certain restrictions placed on the domain extension by it's sp

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

nsoring organization.

Those ccTLD's made available nationwide, or at least with no registration

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

restrictions are, of course, going to be more popular than ones limited to corporations of the c

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ountry for which it stands.

What determines popularity. People do. How do we increase the pop

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

larity of these alternative domain names? Marketing, and education. The best thing to do is ma

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e people aware that they do, in fact, have other options.

Just because .cc is technically the c

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

untry code for the Cocos (Keeling) Islands, or .ad is for Andorra doesn't mean you have to marke

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t it that way. Use some creativity in choosing the best name possible. People remember creativ

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

names.

Again, I cannot stress the importance of keywords. The part of the domain name before

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

he extension is, and always will be the most important aspect of the domain name. So, if your qu

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

stion is, should I buy or invest in ccTLDs, the answer is yes. Though the present return on the

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

se alternative domain names is minimal in comparison to the .com, the future looks promising for

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

certain ccTLDs, for example, Beauty.cc sold for $1,000,000; setting a record for the highest am

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

unt paid for a non .com! I'd say the proof is in the pudding, not to beat an old clich? to death

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/59552/justotherarticles-Its-Raining-ccTLDs.html">It's Raining ccTLD's</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/59552/justotherarticles-Its-Raining-ccTLDs.html]It's Raining ccTLD's[/url]

You have probably seen donation boxes or jars near the cash registers at businesses in your community. These can be a great way to gain, not only money and awareness for your cause, but also publicity for your organization. When placed in high traffic areas a donation box or jar can raise $40 to $60 per month for your organization or cause. That comes to as much at $720 a year per donation box.

Effective marketing is about standing out from the crowd. One way to do this is to use humour. In this article we’ll explain how this can be used and give a few examples.

If you have ever watched any items for sale on an auction you site, you may have wondered why some listings get bids and others don’t, or why two identical items end for drastically different final bids?

Tags

Links

Just Other Articles - It's Raining ccTLD's

Related Articles: